Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$481,600
-$665,000 QoQ
Shares Held
20,000
-55.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#1,780
of 2,821 holders
Holding Since
Dec 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CM Management, LLC holds $4,205,100 across 2 Drug Manufacturers - General names. PFE ranks #2 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OGN |
Organon & Co.
|
275,000 | $3,723,500 | |
| 2 | PFE |
Pfizer Inc
This page
|
20,000 | $481,600 |
All Filings in PFE
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $481,600 | 20,000 | Shares | Sole | 2026-08-13 | |
| 2025-09-30 | $1,146,600 | 45,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,090,800 | 45,000 | Shares | Sole | 2025-08-12 | |
| 2024-09-30 | $1,736,400 | 60,000 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,399,000 | 50,000 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,387,500 | 50,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,439,500 | 50,000 | Shares | Sole | 2024-02-12 | |
| 2021-06-30 | $1,958,000 | 50,000 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,811,500 | 50,000 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $368,100 | 10,000 | Shares | Sole | 2021-02-04 | |
| No filing history on record for this holder in this stock. | ||||||